INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹163 Cr | ₹164 Cr | ₹89 Cr | ₹60 Cr | ₹56 Cr |
What is the latest Contingent Liabilities ratio of INDOCO REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹163 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹56 Cr |
How is Contingent Liabilities of INDOCO REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹163 Cr | -0.60 | |
| Mar2024 | ₹164 Cr | 83.75 | |
| Mar2023 | ₹89 Cr | 48.09 | |
| Mar2022 | ₹60 Cr | 7.79 | |
| Mar2021 | ₹56 Cr | - | |
Compare Contingent Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,359.6 Cr | 4.5% | 24.4% | -22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 4.5% |
24.4% |
-22.5% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses